China looking to go global with vaccine capabilities
This article was originally published in Scrip
China is already the world's largest producer of vaccines in volume terms, manufacturing around a billion doses a year of various products, predominantly for use in its expanded programme of immunisation (EPI). It is now looking to develop this expertise on a wider horizon.
You may also be interested in...
Recent moves show Chinese biotech firms are increasingly looking to go global by recruiting world-class development talent, and J&J names new APAC pharma head.
Join us for a brief audio roundup of the major developments in the international biopharma industry over the past week, as covered by Scrip's global team.
Japanese major builds presence in novel device technology beyond its conventional therapeutics as looks towards a more holistic future of care.